These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 35006395)

  • 1. Cancer non-stem cells as a potent regulator of tumor microenvironment: a lesson from chronic myeloid leukemia.
    Mukaida N; Tanabe Y; Baba T
    Mol Biomed; 2021 Mar; 2(1):7. PubMed ID: 35006395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of histidine decarboxylase activity and cytokine synthesis in human leukemic cell lines: relationship with basophilic and/or megakaryocytic differentiation.
    Dy M; Pacilio M; Arnould A; Machavoine F; Mayeux P; Hermine O; Bodger M; Schneider E
    Exp Hematol; 1999 Aug; 27(8):1295-305. PubMed ID: 10428506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIP-1α/CCL3-expressing basophil-lineage cells drive the leukemic hematopoiesis of chronic myeloid leukemia in mice.
    Baba T; Tanabe Y; Yoshikawa S; Yamanishi Y; Morishita S; Komatsu N; Karasuyama H; Hirao A; Mukaida N
    Blood; 2016 May; 127(21):2607-17. PubMed ID: 27006388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia.
    Sato T; Goyama S; Kataoka K; Nasu R; Tsuruta-Kishino T; Kagoya Y; Nukina A; Kumagai K; Kubota N; Nakagawa M; Arai S; Yoshimi A; Honda H; Kadowaki T; Kurokawa M
    Oncogene; 2014 Oct; 33(42):5028-38. PubMed ID: 24747972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basophils in Tumor Microenvironment and Surroundings.
    Marone G; Gambardella AR; Mattei F; Mancini J; Schiavoni G; Varricchi G
    Adv Exp Med Biol; 2020; 1224():21-34. PubMed ID: 32036602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells--new approach to cancerogenensis and treatment.
    Macingová Z; Filip S
    Acta Medica (Hradec Kralove); 2008; 51(3):139-44. PubMed ID: 19271680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation.
    Cui P; Zhang Y; Cui M; Li Z; Ma G; Wang R; Wang N; Huang S; Gao J
    Leuk Res; 2018 Feb; 65():49-54. PubMed ID: 29306107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting BMP signaling in the bone marrow microenvironment of myeloid leukemia.
    Lefort S; Maguer-Satta V
    Biochem Soc Trans; 2020 Apr; 48(2):411-418. PubMed ID: 32167132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia.
    Mukaida N; Tanabe Y; Baba T
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28829353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cells.
    Park CS; Lacorazza HD
    Exp Mol Med; 2020 Oct; 52(10):1663-1672. PubMed ID: 33067577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic silencing of p15.
    Gao S; Zhou B; Li H; Huang X; Wu Y; Xing C; Yu X; Ji Y
    Exp Hematol; 2018 Nov; 67():32-40.e3. PubMed ID: 30172749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity.
    Hope KJ; Jin L; Dick JE
    Nat Immunol; 2004 Jul; 5(7):738-43. PubMed ID: 15170211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of embryonic stem cell markers in acute myeloid leukemia.
    Picot T; Aanei CM; Fayard A; Flandrin-Gresta P; Tondeur S; Gouttenoire M; Tavernier-Tardy E; Wattel E; Guyotat D; Campos L
    Tumour Biol; 2017 Jul; 39(7):1010428317716629. PubMed ID: 28718379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Stem Cells in the Immune Microenvironment.
    Lee DS; Oh K
    Adv Exp Med Biol; 2021; 1187():245-266. PubMed ID: 33983582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia stem cells and human acute lymphoblastic leukemia.
    Bernt KM; Armstrong SA
    Semin Hematol; 2009 Jan; 46(1):33-8. PubMed ID: 19100366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecotropic viral integration site 1, stem cell self-renewal and leukemogenesis.
    Kataoka K; Kurokawa M
    Cancer Sci; 2012 Aug; 103(8):1371-7. PubMed ID: 22494115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells.
    Carlsten M; Järås M
    Front Immunol; 2019; 10():2357. PubMed ID: 31681270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Niche Competition Between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells.
    Glait-Santar C; Desmond R; Feng X; Bat T; Chen J; Heuston E; Mizukawa B; Mulloy JC; Bodine DM; Larochelle A; Dunbar CE
    Stem Cells; 2015 Dec; 33(12):3635-42. PubMed ID: 26388434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of new biochemical and immunohistochemical parameters in chronic myeloid leukemia.
    Valent P; Agis H; Sperr W; Sillaber C; Horny HP
    Leuk Lymphoma; 2008 Apr; 49(4):635-8. PubMed ID: 18398724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis.
    Vianello F; Villanova F; Tisato V; Lymperi S; Ho KK; Gomes AR; Marin D; Bonnet D; Apperley J; Lam EW; Dazzi F
    Haematologica; 2010 Jul; 95(7):1081-9. PubMed ID: 20179085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.